Aytu BioScience (NASDAQ:AYTU) is a dynamic healthcare company engaged in developing and commercializing novel products in the fields of pediatrics and reproductive health. Among its innovative offerings are treatments for conditions ranging from sleep disorders to testosterone replacement therapy. The company's mission revolves around addressing unmet or underserved medical needs, aiming to improve patient care with its diversified portfolio. Aytu BioScience is committed to expanding its presence in the healthcare industry through strategic acquisitions, research and development, and collaborations that enhance its product range and market reach.